ArticleHaemophilia : the official journal of the World Federation of Hemophilia2021

The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.

Mark W Skinner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.